| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.002 |